D. Gary Gilliland

Fred Hutchinson Cancer Research Center has named cancer genetics and precision medicine expert D. Gary Gilliland as its new president and director. Gilliland will assume his new role on Jan. 2. Gilliland previously was vice president of precision medicine at the University of Pennsylvania's Perelman School of Medicine. Before that he was an executive at Merck Research Laboratories and spent two decades at Harvard Medical School teaching medicine and investigating the genetic basis of blood cancers. His work has led to the development of a number of personalized cancer therapies.